Camtek Ltd. diskutieren
Camtek (NASDAQ:CAMT) had its price target raised by analysts at Needham & Company LLC from $125.00 to $135.00. They now have a "buy" rating on the stock.
Ratings data for CAMT provided by MarketBeat
Camtek (NASDAQ:CAMT) had its price target raised by analysts at Bank of America Corporation from $140.00 to $160.00. They now have a "buy" rating on the stock.
Ratings data for CAMT provided by MarketBeat
Camtek (NASDAQ:CAMT) had its price target raised by analysts at Needham & Company LLC from $135.00 to $160.00. They now have a "buy" rating on the stock.
Ratings data for CAMT provided by MarketBeat
Camtek (NASDAQ:CAMT) had its "buy" rating reaffirmed by analysts at B. Riley.
Ratings data for CAMT provided by MarketBeat
Camtek (NASDAQ:CAMT) had its "outperform" rating reaffirmed by analysts at Evercore Inc.
Ratings data for CAMT provided by MarketBeat


Neueste Beiträge
Royal_Bank_of_Canada in Rhythm Pharmaceuticals diskutieren